I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hara, Hiroki
1374
results:
Search for persons
X
Format
Online (1374)
Mediatypes
Articles (Online) (781)
Bookchapter (Online) (19)
OpenAccess-fulltext (574)
Languages
english (1262)
Sorted by: Relevance
Sorted by: Year
?
1
Impacts of tumor microenvironment during neoadjuvant chemot..:
Sugawara, Kotaro
;
Fukuda, Takashi
;
Murakami, Chiaki
...
Cancer Science. , 2024
Link:
https://doi.org/10.1111/..
?
2
Second-line tislelizumab versus chemotherapy in Japanese pa..:
Hara, Hiroki
;
Satoh, Taroh
;
Kojima, Takashi
...
Esophagus. 21 (2024) 2 - p. 102-110 , 2024
Link:
https://doi.org/10.1007/..
?
3
Optimizing Organ Preservation Strategies through Chemothera..:
Katada, Chikatoshi
;
Yokoyama, Tetsuji
;
Watanabe, Akinori
...
International Journal of Radiation Oncology*Biology*Physics. , 2024
Link:
https://doi.org/10.1016/..
?
4
First-line pembrolizumab plus chemotherapy for advanced/met..:
Kato, Ken
;
Kojima, Takashi
;
Hara, Hiroki
...
Esophagus. 21 (2024) 3 - p. 306-318 , 2024
Link:
https://doi.org/10.1007/..
?
5
Doublet chemotherapy, triplet chemotherapy, or doublet chem..:
Kato, Ken
;
Machida, Ryunosuke
;
Ito, Yoshinori
...
The Lancet. 404 (2024) 10447 - p. 55-66 , 2024
Link:
https://doi.org/10.1016/..
?
6
A first-in-human phase I study of TAS-117, an allosteric AK..:
Doi, Toshihiko
;
Takahashi, Shunji
;
Aoki, Daisuke
...
Cancer Chemotherapy and Pharmacology. 93 (2024) 6 - p. 605-616 , 2024
Link:
https://doi.org/10.1007/..
?
7
Risk prediction model for cisplatin-induced acute kidney in..:
Imamura, Yoshinori
;
Kiyota, Naomi
;
Tahara, Makoto
...
Oral Oncology. 154 (2024) - p. 106868 , 2024
Link:
https://doi.org/10.1016/..
?
8
Multiomic molecular characterization of the response to com..:
Takei, Shogo
;
Tanaka, Yosuke
;
Lin, Yi-Tzu
...
Journal for ImmunoTherapy of Cancer. 12 (2024) 2 - p. e008210 , 2024
Link:
https://doi.org/10.1136/..
?
9
Phase II Study of the Liposomal Formulation of Eribulin (E7..:
Kawazoe, Akihito
;
Yamamoto, Noboru
;
Sugimoto, Naotoshi
...
Clinical Cancer Research. 30 (2024) 7 - p. 1264-1272 , 2024
Link:
https://doi.org/10.1158/..
?
10
Site of distant metastasis affects the prognosis with recur..:
Hoshi, Yuta
;
Shirakura, Satoshi
;
Yamada, Masato
...
International Journal of Clinical Oncology. 28 (2023) 9 - p. 1139-1146 , 2023
Link:
https://doi.org/10.1007/..
?
11
Efficacy of Pembrolizumab Monotherapy in Japanese Patients ..:
Muro, Kei
;
Shitara, Kohei
;
Yamaguchi, Kensei
...
Journal of Gastrointestinal Cancer. 54 (2023) 3 - p. 951-961 , 2023
Link:
https://doi.org/10.1007/..
?
12
Survival Impacts of Impaired Lung Functions and Comorbiditi..:
Sugawara, Kotaro
;
Oka, Daiji
;
Hara, Hiroki
..
World Journal of Surgery. 47 (2023) 12 - p. 3229-3239 , 2023
Link:
https://doi.org/10.1007/..
?
13
ASO Visual Abstract: The Impact of Pretreatment Esophageal ..:
Sugawara, Kotaro
;
Fukuda, Takashi
;
Kishimoto, Yutaka
...
Annals of Surgical Oncology. 30 (2023) 5 - p. 2715-2715 , 2023
Link:
https://doi.org/10.1245/..
?
14
Nivolumab versus irinotecan as third- or later-line treatme..:
Kumanishi, Ryosuke
;
Kadowaki, Shigenori
;
Mitani, Seiichiro
...
International Journal of Clinical Oncology. 28 (2023) 6 - p. 756-763 , 2023
Link:
https://doi.org/10.1007/..
?
15
Pembrolizumab for previously treated, microsatellite instab..:
Le, Dung T.
;
Diaz Jr., Luis A.
;
Kim, Tae Won
...
European Journal of Cancer. 186 (2023) - p. 185-195 , 2023
Link:
https://doi.org/10.1016/..
1-15